Wealthspire Advisors (New York)’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$9.44M Sell
50,854
-2,888
-5% -$536K 0.05% 122
2025
Q1
$11.3M Sell
53,742
-1,473
-3% -$309K 0.07% 104
2024
Q4
$9.81M Sell
55,215
-539
-1% -$95.8K 0.1% 96
2024
Q3
$11M Buy
55,754
+6,081
+12% +$1.2M 0.11% 93
2024
Q2
$8.52M Sell
49,673
-3,615
-7% -$620K 0.11% 88
2024
Q1
$9.7M Sell
53,288
-2,018
-4% -$367K 0.13% 76
2023
Q4
$8.57M Sell
55,306
-177
-0.3% -$27.4K 0.12% 79
2023
Q3
$8.27M Buy
55,483
+9,072
+20% +$1.35M 0.14% 77
2023
Q2
$6.25M Sell
46,411
-551
-1% -$74.2K 0.1% 87
2023
Q1
$7.48M Sell
46,962
-3,853
-8% -$614K 0.13% 80
2022
Q4
$8.21M Buy
50,815
+2,578
+5% +$417K 0.15% 79
2022
Q3
$6.47M Buy
48,237
+446
+0.9% +$59.9K 0.14% 81
2022
Q2
$7.32M Buy
47,791
+3,153
+7% +$483K 0.15% 72
2022
Q1
$7.24M Sell
44,638
-10,433
-19% -$1.69M 0.16% 57
2021
Q4
$7.46M Buy
55,071
+35,007
+174% +$4.74M 0.17% 60
2021
Q3
$2.16M Buy
20,064
+10,739
+115% +$1.16M 0.04% 159
2021
Q2
$1.05M Sell
9,325
-27,263
-75% -$3.07M 0.03% 159
2021
Q1
$3.96M Buy
36,588
+6,694
+22% +$725K 0.09% 106
2020
Q4
$3.2M Sell
29,894
-11,565
-28% -$1.24M 0.1% 98
2020
Q3
$3.63M Buy
41,459
+4,486
+12% +$393K 0.22% 56
2020
Q2
$3.63M Buy
36,973
+3,980
+12% +$391K 0.25% 47
2020
Q1
$2.51M Buy
32,993
+23,205
+237% +$1.77M 0.11% 108
2019
Q4
$867K Buy
9,788
+1,245
+15% +$110K 0.06% 70
2019
Q3
$647K Buy
8,543
+4,507
+112% +$341K 0.05% 69
2019
Q2
$293K Buy
+4,036
New +$293K 0.03% 74
2019
Q1
Sell
-1,757
Closed -$162K 50
2018
Q4
$162K Buy
+1,757
New +$162K 0.02% 77